StockSnips AI-Powered Sentiment US All Cap ETF (NASDAQ:NEWZ – Get Free Report) was the target of a significant growth in short interest in November. As of November 15th, there was short interest totalling 13,600 shares, a growth of 312.1% from the October 31st total of 3,300 shares. Based on an average daily trading volume, of 5,200 shares, the days-to-cover ratio is currently 2.6 days.
StockSnips AI-Powered Sentiment US All Cap ETF Stock Performance
Shares of NEWZ traded down $0.21 during midday trading on Wednesday, reaching $29.70. The stock had a trading volume of 21,503 shares, compared to its average volume of 9,827. The firm has a 50 day simple moving average of $28.53 and a 200-day simple moving average of $27.23. StockSnips AI-Powered Sentiment US All Cap ETF has a one year low of $24.35 and a one year high of $29.91.
StockSnips AI-Powered Sentiment US All Cap ETF Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Monday, September 30th. Investors of record on Friday, September 27th were issued a dividend of $0.0073 per share. This represents a $0.03 dividend on an annualized basis and a yield of 0.10%. The ex-dividend date was Friday, September 27th.
Institutional Trading of StockSnips AI-Powered Sentiment US All Cap ETF
About StockSnips AI-Powered Sentiment US All Cap ETF
The StockSnips AI-Powered Sentiment US All Cap ETF (NEWZ) is an exchange-traded fund that mostly invests in total market equity. The fund pursues long-term capital appreciation by actively managing a narrow portfolio of US companies across various market capitalizations. The fund selects securities by blending Artificial Intelligence (AI) and Natural Language Processing (NLP) technologies.
Read More
- Five stocks we like better than StockSnips AI-Powered Sentiment US All Cap ETF
- How to Invest in Biotech Stocks
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What Are the FAANG Stocks and Are They Good Investments?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What Investors Need to Know to Beat the Market
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for StockSnips AI-Powered Sentiment US All Cap ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for StockSnips AI-Powered Sentiment US All Cap ETF and related companies with MarketBeat.com's FREE daily email newsletter.